Veda Trials
Veda Trials is a community-based clinical operations company that partners with community healthcare organizations and local providers to run end-to-end clinical trials. Its research enablement platform streamlines site activation and reduces operational burden in decentralized community care settings across the United States.
- Company typePrivate
- Founded2023
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Veda Trials does
Veda Trials (legal entity: Veda Life Sciences, Inc.) is a community-based clinical operations company founded in 2023 in Boston, Massachusetts. The company partners with community-based healthcare organizations and local providers to establish or enhance research operations, enabling end-to-end clinical trial execution in community care settings where broad patient populations can participate. Veda's core offering is a research enablement platform that streamlines site activation, reduces operational burden, and supports patient enrollment and data quality across decentralized clinical sites throughout the United States. The company's go-to-market is community-led and partnership-driven, with revenue generated through managed services (clinical operations support and technology access) provided to community clinics and, implicitly, to the trial sponsors whose studies are run at those sites.
Veda was originally backed by Redesign Health as its first institutional investor. On February 4, 2026, the company was acquired by Lightship Inc., a site-network and hybrid clinical trial delivery operator. Post-acquisition, Veda operates within Lightship's operations group, combining its community-based site network and operational platform with Lightship's broader site network, hybrid delivery model, and mobile research services. Founder and CEO Lesley Solomon continues in her role, reporting to Lightship CEO David MacMurchy. Near-term priorities focus on aligning SOPs across the combined entity and accelerating activation of existing Veda partner clinics. The company maintains a small team (1-10 employees) and serves community clinics and local providers as its primary customer base, with pharma, biotech, and life sciences trial sponsors as a secondary segment.
Veda Trials firmographics
Firmographics- Name
- Veda Trials
- Legal name
- Veda Life Sciences, Inc.
- Website
- https://vedatrials.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- Veda Trials is a community-based clinical operations company that partners with community healthcare organizations and local providers to run end-to-end clinical trials. Its research enablement platform streamlines site activation and reduces operational burden in decentralized community care settings across the United States.
- Ownership category
- akta.pro rank
Veda Trials industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH), Clinical Trial Patient Recruitment & Retention (HLAGACAD)
Keywords
Where Veda Trials is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Markets served
Veda Trials business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Operations Services: Veda provides end-to-end clinical trial operations services to community-based healthcare organizations, enabling them to conduct clinical trials. Revenue is generated through service fees for research enablement, technology access, and operational support provided to partner clinics.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Veda Trials product offering
Product offeringCore offering
Veda Trials provides end-to-end clinical trial operations services and a research enablement platform that allows community-based healthcare organizations and local providers to run clinical trials in their own care settings. The company's replicable model combines technology that streamlines site activation with operational support that reduces day-to-day trial execution burden, enabling broad and diverse patient populations to participate in clinical research.
Product overview
Veda Trials offers a unified research enablement platform focused on end-to-end clinical trial operations. The company provides technology that enables community clinics and local providers to execute clinical trials by simplifying day-to-day trial execution and reducing operational burden. The core platform supports site activation, patient enrollment, and data quality maintenance across community-based clinical settings throughout the United States.
Differentiator
Problem solved
Functional benefit
Products and services
- Veda Trials Platform A research enablement platform that leads end-to-end clinical trial operations for community-based clinical sites, enabling community clinics and local providers to run trials through technology that streamlines site activation and reduces operational burden, supporting patient enrollment and data quality in local care settings.
Companies that use Veda Trials
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Veda Trials technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Veda Trials partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Veda Trials competitors and assessment
Company assessmentDirect peers
- Curavit Clinical Research: Curavit is a fully decentralized clinical trial CRO focused on virtual and hybrid trial design and execution — directly comparable to Veda's DCT operating model and overlapping target customer base of pharma and biotech sponsors.
- ObvioHealth: ObvioHealth is a DCT-focused CRO running fully decentralized and hybrid trials with integrated site services and technology — directly comparable to Veda in serving sponsors seeking non-traditional site execution models.
- Javara Research: Javara operates an integrated clinical research site network embedded within community healthcare organizations, providing centralized infrastructure for community-based trials — directly aligned with Veda's community-clinic enablement model.
- Science 37: Science 37 is a leading decentralized clinical trial operator delivering fully remote and hybrid trial execution through its site network and technology platform — directly comparable to Veda in enabling clinical research outside traditional site settings.
- Lightship Inc. Lightship is Veda Trials' parent company following the February 2026 acquisition, operating a hybrid and decentralized clinical trial site network with mobile research services — directly comparable operating model now extended with community-based clinics.
- EmVenio Research (PCM Trials): EmVenio (formed from the PCM Trials merger) operates community-based and mobile clinical research sites for decentralized trials — directly comparable to Veda's community-site model and overlapping sponsor customer base.
Emerging players
- Medable: Medable provides a DCT technology platform (eCOA, eConsent, telehealth, remote monitoring) used by sponsors and sites to run decentralized trials — comparable as an enabling layer for community-based trial execution, though Medable is primarily software rather than site operations.
Broad incumbents
- Velocity Clinical Research: Velocity is a large multi-site clinical research organization operating dedicated research sites across the US — comparable as a site-network operator serving sponsors, though its model is purpose-built sites rather than community-clinic embedded.
- Clinipace Worldwide: Clinipace is a mid-sized CRO offering clinical operations, site management, and biostatistics services to sponsors — comparable as a broader incumbent competitor for sponsor contracts that include site operations components.
- IQVIA: IQVIA is the largest global CRO with extensive site management organization (SMO) services and decentralized trial capabilities — comparable as a broad incumbent offering overlapping site operations and DCT services to pharma sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights6 records
Customer concentration
Veda Trials social profiles
Digital presenceVeda Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Veda Trials leadership team
Management profileNumber of profiles
Profiles1 record
Veda Trials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Veda Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Veda Trials
What does Veda Trials do?
Veda Trials provides end-to-end clinical trial operations services and a research enablement platform that allows community-based healthcare organizations and local providers to run clinical trials in their own care settings. The company's replicable model combines technology that streamlines site activation with operational support that reduces day-to-day trial execution burden, enabling broad and diverse patient populations to participate in clinical research.
Is Veda Trials a public or private company?
Veda Trials is a private company. It is classified as corporate owned and is currently acquired.
When was Veda Trials founded?
Veda Trials was founded in 2023. It employs 1 to 10 people.
Where is Veda Trials based?
Veda Trials is headquartered in Boston, United States, in the North America region.
How does Veda Trials make money?
One revenue line is on record: clinical Operations Services.
Who are Veda Trials's main competitors?
Direct peers on record are Curavit Clinical Research, ObvioHealth, Javara Research, Science 37, Lightship Inc. and EmVenio Research (PCM Trials). Medable is listed as an emerging player. Broad incumbents are Velocity Clinical Research, Clinipace Worldwide and IQVIA.
Does Veda Trials have an API?
No public API is recorded for Veda Trials.
What industry is Veda Trials in?
Veda Trials's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8000.